Suranjith Seneviratne, MBBS, MD, FRCP, FRCPath, DPhil (Oxon), FCCP, completed his basic Medical Degree with First Class Honours, eight distinctions and ten Gold medals and was placed first in his year. He completed his MD in Internal Medicine and trained in Clinical Immunology and Allergy at the John Radcliffe Hospital in Oxford. He completed a DPhil in Molecular Immunology and Allergy at the Weatherall Institute of Molecular Medicine, University of Oxford as a Commonwealth Scholar. He is currently a Consultant in Clinical Immunology and Allergy at the Royal Free Hospital and University College London. Dr. Seneviratne is the Director of the Centre for Mast Cell Disorders and the President of the UK-Sri Lanka Immunology Foundation, an organisation that contributes to Immunology and Allergy education in Sri Lanka. He has managed the Mast Cell/Histamine/Immunology/Allergy aspects of over 500 patients with EDS during the past 4 years. He has authored 120 journal publications and was one of the UK principal investigators in the recently completed Pan-European adult Food Allergy study (EUROPREVALL). At present, he is the Principal Investigator of the STILLPAD-UK study, a prospective study of lung disease in Immunodeficiency. He is a member of the NIHR Bio-resource Genetic study on Primary Immunodeficiency patients and is involved in several molecular genetic studies on patients with Mast Cell Activation Disorder, CVID, Hyper IgM syndrome, LRBA deficiency, Hyper IgE syndrome, Complement deficiencies and Food Allergy.
Mast Cell (Sri Lanka and UK)